Medicine and Dentistry
Anifrolumab
100%
Lupus Erythematosus
75%
Discoid Lupus Erythematosus
62%
Miliary Tuberculosis
50%
Medicine
50%
Hematopoietic Stem Cell
50%
Digital Imaging
50%
Transplantation
50%
Subacute Cutaneous Lupus Erythematosus
50%
Radiation Therapy Planning
50%
Stereotactic Body Radiation Therapy
50%
Angiography
50%
Intensity Modulated Radiation Therapy
50%
Systemic Lupus Erythematosus
50%
Arm
50%
Pancreas Cancer
50%
Cerebral Arteriovenous Malformation
50%
Volume CT
50%
Volumetric Modulated Arc Therapy
50%
Lenalidomide
50%
Magnetic Resonance Angiography
44%
Postprimary Tuberculosis
20%
Diffuse Palmoplantar Keratoderma
12%
Disease
12%
Hydroxychloroquine
12%
Clinical Trial
12%
Infection
12%
Autoimmune Disease
12%
Digital Subtraction Angiography
11%
Computed Tomography Angiography
11%
Magnetic Resonance Imaging
11%
Pustule
10%
Sepsis
10%
Acid-Fast
10%
Tuberculosis
10%
Mycobacterial Infection
10%
Adenovirus Infection
10%
Mycobacterium Tuberculosis
10%
Skin Biopsy
10%
Dermatoscopy
7%
Nodular Melanoma
7%
Diagnostic Imaging
7%
Dermatology
7%
Consumer
7%
Lupus Erythematosus Panniculitis
6%
Monoclonal Antibody
6%
Mycophenolic Acid
6%
Belimumab
6%
Interferon Receptor
6%
Calcinosis Cutis
6%
Keyphrases
Tuberculosis
50%
Disseminated Tuberculosis
50%
Atypical Cutaneous Manifestations
50%
Hematopoietic Cell Transplant
50%
Transplant Patients
50%
SERPINB7
50%
Post-transplant Period
50%
Work Item
50%
Anifrolumab
50%
Discoid Lupus Erythematosus
50%
Lenalidomide
50%
Tuberculosis Reactivation
25%
Lupus
25%
Araneidae
16%
Spider Fear
16%
Cone-beam Computed Tomography Angiography
14%
Unusual Case
12%
Systemic Infection
12%
Active Tuberculosis
12%
Risk Factors
12%
Skin Biopsy
12%
Mycobacterium Tuberculosis (M. tb)
12%
Tissue Staining
12%
Cutaneous Presentation
12%
Infection Reactivation
12%
Paucity
12%
Acid-fast
12%
Pustules
12%
Epidemiological Risk
12%
3D Capture
12%
Adenovirus Infection
12%
Disseminated Adenovirus
12%
Histopathological Examination
12%
Full-body Imaging
12%
3D Textured Mesh
12%
Mycobacterial Infection
12%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
12%
Older Patients
12%
Hydroxychloroquine
12%
Major Infections
12%
Further Treatment
12%
Treatment Initiation
12%
Autoimmune Disease
12%
Clinical Trials
12%
Treatment Options
12%
Initial Treatment
12%
Symptom Improvement
12%
Initial Diagnosis
12%
Standard of Care
12%
Combinational Approaches
12%
